The Cyprus pulmonology society on Thursday urged Well being Minister Michael Damianos to approve a respiratory syncytial virus (RSV) vaccine to be used Cyprus.
The society additionally seeks its inclusion into the federal government’s vaccination programme below Gesy.
The RSV vaccine helps to guard in opposition to the respiratory syncytial virus, which is a standard reason behind coughs and colds. The illness could cause pneumonia and bronchiolitis amongst infants and the aged and produce about critical respiratory issues.
As such, in different international locations, the RSV vaccine is obtainable and advisable to sure inhabitants teams.
In the UK, for instance, the nation’s nationwide well being service recommends the vaccine for pregnant girls and all folks aged between 75 and 79 years previous.
Pulmonology society chairman Dr Alexis Papadopoulos, highlighted RSV because the main reason behind viral decrease respiratory infections in youngsters.
The society recommends vaccination with both of the 2 Rsv vaccines (RSVPreF3 and RSVpreF), which have been permitted by the European medicines company in 2023.
The advice comes as hospitals are battling elevated admissions, whereas medical doctors report a surge in circumstances of flu-like signs amongst sufferers
The society strongly advises vaccination for high-risk teams. These embrace sufferers with cystic fibrosis, extreme interstitial lung illness, pulmonary hypertension, and power obstructive pulmonary illness (COPD), and people with coronary heart situations.
It additionally recommends the vaccine for bronchial asthma sufferers, particularly these with extreme kinds, and people over 60 years previous with situations similar to diabetes, coronary heart illness, hypertension, stroke, power kidney or liver illness, and immune issues. It additional advises vaccination for all people over the age of 75.
